PlexBio Co., Ltd. (TPEX:6572)
7.65
-0.04 (-0.52%)
Aug 26, 2026, 1:42 PM CST
PlexBio Market Cap
PlexBio has a market cap or net worth of 797.06 million as of August 26, 2026. Its market cap has decreased by -21.05% in one year.
Market Cap
797.06M
Enterprise Value
519.10M
Revenue
137.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.65
ChartMarket Cap Chart
Since February 26, 2016, PlexBio's market cap has decreased from 1.58B to 797.06M, a decrease of -49.53%. That is a compound annual growth rate of -6.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 797.06M | -1.16% |
| Dec 31, 2025 | 806.39M | -37.00% |
| Dec 31, 2024 | 1.28B | -12.41% |
| Dec 29, 2023 | 1.46B | 17.01% |
| Dec 30, 2022 | 1.25B | -32.68% |
| Dec 30, 2021 | 1.86B | -23.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 25, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bioptik Technology Incorporation | 1.38B |
| Rossmax International | 1.09B |
| NaviFUS | 1.09B |
| S&S Healthcare Holding | 986.02M |
| Wiltrom | 979.59M |
| Diamond Biotechnology | 962.85M |
| Cowealth Medical Holding | 906.34M |
| AmCad BioMed | 842.33M |